2023
DOI: 10.1093/database/baac109
|View full text |Cite
|
Sign up to set email alerts
|

Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is

Abstract: Von Hippel–Lindau (VHL) disease is a rare, autosomal dominant disorder that predisposes individuals to developing tumors in many organs. There is significant phenotypic variability and genetic variants encountered within this syndrome, posing a considerable challenge to patient care. The lack of VHL variant data sharing paired with the absence of aggregated genotype–phenotype information results in an arduous process, when characterizing genetic variants and predicting patient prognosis. To address these gaps … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…The integration of IthaPhen with other databases of the constantly updated ITHANET portal provides the community with a valuable expanding dataset of case‐level data with rich phenotypic annotation and ensures its sustainability. In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs 19 . Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies.…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…The integration of IthaPhen with other databases of the constantly updated ITHANET portal provides the community with a valuable expanding dataset of case‐level data with rich phenotypic annotation and ensures its sustainability. In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs 19 . Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies.…”
Section: Figurementioning
confidence: 99%
“…In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs. 19 Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies. Notably, we demonstrated the utility of IthaPhen with 2 examples in (a) genotype-phenotype correlation and (b) standardized variant classification, illustrating how IthaPhen can contribute to data-driven and quantitative approaches in the field of hemoglobinopathies.…”
mentioning
confidence: 99%